Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 3/1998

01-03-1998

Endoscopic Sclerotherapy in Porcine Esophagus Changes Luminal Cross-Sectional Area and Wall Distensibility Dose- and Time-Dependently

Authors: Jens Aage, Kolsen Petersen, Christian Djurhuus, Jonathan Koff, Lars Vinter-Jensen, Hans Gregersen

Published in: Digestive Diseases and Sciences | Issue 3/1998

Login to get access
Metadata
Title
Endoscopic Sclerotherapy in Porcine Esophagus Changes Luminal Cross-Sectional Area and Wall Distensibility Dose- and Time-Dependently
Authors
Jens Aage
Kolsen Petersen
Christian Djurhuus
Jonathan Koff
Lars Vinter-Jensen
Hans Gregersen
Publication date
01-03-1998
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 3/1998
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1023/A:1018802922374

Other articles of this Issue 3/1998

Digestive Diseases and Sciences 3/1998 Go to the issue

OriginalPaper

Ketotifen Therapy for Acute Ulcerative Colitis in Children (A Pilot Study)

OriginalPaper

Expression of E-Selectin, Sialyl Lewis X, and Macrophage Inflammatory Protein-1α by Colonic Epithelial Cells in Ulcerative Colitis

OriginalPaper

Qualitative Changes in Enteric Flora and Short-Chain Fatty Acids After Intestinal Resection

OriginalPaper

Interleukin-1β Inhibits Growth Factor-Stimulated Restoration of Wounded Rat Gastric Epithelial Cell Monolayers

OriginalPaper

Plasma Cholecystokinin and Gallbladder Responses to Increasing Doses of Bombesin in Celiac Disease

OriginalPaper

Postprandial Cholecystokinin Response in Patients with Chronic Pancreatitis in Treatment with Oral Substitutive Pancreatic Enzymes
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits